While semaglutide itself may not be the issue, eating too many potassium-rich foods can be a concern for some people, especially those with kidney issues
When you use semaglutide, your GLP-1 receptors experience sustained stimulation
The STEP (Semaglutide Treatment Effect in People with Obesity) trials represent the most comprehensive safety data available for semaglutide at the 2.4 mg weight loss dose
N., Penzel, T., & Fietze, I
Appropriate management of respiratory symptoms in patients taking GLP-1 medications requires systematic clinical evaluation to identify the underlying cause and implement targeted interventions
Significant weight changes during or after reconstruction (whether DIEP flap, implant exchange, or fat grafting) can affect symmetry, fit, and aesthetic results